ABSTRACT
INTRODUCTION
Infection in the burn unit has been under intense study over the past few decades (Gikas et al., 2000; Pruitt et al., 1998) . Immunucompromised or critically ill patients are at high risk of getting the hospital acquired infections. Bacterial infections following severe burn injuries can be most simplistically attributed to extensive breaches in the skin barrier. The fact that Pseudomonas aeruginosa occurs so commonly in the environment makes it extremely likely that an individual suffering severe burns will be challenged with this micro-organism before the burns can heal (Erol et al., 2004) . Since this bacterium is naturally resistant to many drugs and is able to get resistance to all effective antimicrobials, the infection with this organism is particularly problematic condition for patients.
Burn units are known to harbour multidrug resistant (MDR) Pseudomonas aeruginosa that can serve as source of infection (Rossolini et al., 2005) . Apart from the inanimate hospital environment,bacterial flora is also carried into a hospital by the patient and can be an important source of infection for the same individuals after burn injuries. The worst scenario occurs when such strain cross contaminate other burn victims and can persist throughout several course of antibiotic treatment. In an outbreak of P. aeruginosa in a hospital, including a medical/surgical unit, a stepdown and a transplant unit, more environmental strains of the bacteria was recovered from sink drains and faucet heads than from equipment such as respiratory equipment, intravenous monitors, dispensing machines, ice machines, fluid dispensers and scissor hooks. (Hota et al., 2009) .
In another study that reviewed a 6-year antibiotic susceptibility record to assess the prevalence of MDR isolates at a US Army burn center, Acinetobacter baumannii (22%) was found to be most prevalent organism recovered, followed by Pseudomonas aeruginosa (20%) (Keen et al., 2010) . P. aeruginosa, was also found to be resistant to all 4 classes of antibiotics tested in the study, including colistin. ISSN (print): 1823 -8262, ISSN (online): 2231 Antibiotic susceptibility test is therefore imperative as it guides the selection of an effective regimen of the treatment of Pseudomonas aeruginosa infections. Data from antibiograms are most useful when initiating empiric therapy or when tracking antimicrobial resistance over time within a hospital or health care system (Agnihotri et al., 2004) . Accordingly our work sought to determine the profile of drug susceptibility and colonization routes of Pseudomonas aeruginosa isolated from burn injuries with a view to making informed decisions on the choice of effective clinical management of the disease burden.
*Corresponding author

MATERIALS AND METHODS
The University of Calabar Teaching Hospital (UCTH) is one of the many referral centres in South-South Nigeria, for patients with severe burn injuries. Patients were hospitalized in the burn unit following different types of burn injuries; gasoline (n = 15), oil (n=18), boiling water (n= 44), flame (n=6) acid (n=3). The age range of patients was classified as follows: under 15 (n=46), 15 to 40 (n=20), above 40 (n=14).There were altogether 49 male and 31 female patients. Clinical samples included burn wounds swabs; environmental samples (78) were water from faucets, swabs from sinks, floors, door handles, dressing trolleys, hand impressions of staff, antiseptics and other areas with potentials for cross contamination though out the burn unit.
Samples were collected and processed on a weekly basis for a period of 3 months, June to August, 2009 after due ethical considerations.
Altogether 158 samples (Clinical and environmental) were obtained. Samples were cultured on Mueller-Hinton agar at 37 °C for 34 hours by the disk diffusion method described by KirbyBauer (Bauer et al., 1966) . Pseudomonas aeruginosa isolates were identified to specie level using standard laboratory procedures (Kiska, et al., 2003) . Drug susceptibility tests were done for all isolates by Bauer-Kirby agar diffusion method for the following antimicrobial agents amikacin (30 µg), aztreonam (10 µg) cefotaxime (10 µg) ceftazidime (10 µg) ceftizoxime (10 µg ) ciprofloxacin (5 µg ) gentamicin (10 µg) imipenem (10 µg) Kanamycin (30 µg) meropenem (10 µg) piperacillin (100 µg) piperacillin/tazobactam (100/10 µg) polymyixin β (300 units) (Mast diagnostics, Merseyside, UK). CLSI breakpoints were used to determine susceptibility (CLSI, 2006) . Quality control was carried out using standard strain of Pseudomonas aeruginosa (ATCC 12278) . Multidrug resistant (MDR) Pseudomonas aeruginosa isolates were those resistant to ceftazidime and at least 3 of the following antibiotics, amikacin, aztreonam, ciprofloxacin, gentamicin, imipenem, piperacillin and aminoglycoside.
RESULTS
Out of a total number of 86 patients admitted in the Burn Unit (BU), 80 with serious burn injuries (90%) were included in this study; 46 (60%) were under 15, 20 (25%) between 15 and 40 yr while 14 (17.5%) were above 40; 49 (61.3%) were male 31 (38.8%) were female. The median length of burn unit stay was 29 days.
During the course of the surveillance study, environmental samples (78) 
DISCUSSION
Pseudomonas aeruginosa isolated from burn injuries have significant effect on the mortality and morbidity in hospitalized burn patients particularly in a developing country such as ours. Here, we evaluated the colonization route (cross transmission mode) and drug susceptibility pattern of Pseudomonas aeruginosa in a tertiary burn unit. In our study, more male, (73%) and child (57%) patients were admitted into the burn unit. The reason may be a combination of factors such as male dominant activity, child restiveness and poor safety consciousness in our society. When compared to other studies in community based hospitals (Gikas et al., 2002; Lari et al., 2000) , nosocomial infections of burn injuries carried by Pseudomonas aeruginosa were higher with a prevalence of 51.3% in the present study. These differences are partly due to the fact that our facility is largely a referral centre with intensive support therapies and hence more vulnerable to developing nosocomial Pseudomonas aeruginosa infections.
It also appears a greater tendency towards increased susceptibility (82%) was evident in combination therapeutic antibacterial regimen, particularly where synergy exist (Harris et al., 1999; Rossolini et al., 2005) . Cross acquisition seems to play an important role in the epidemiology of nosocomial colonization of infection with Pseudomonas aeruginosa. Understanding the route of colonization is crucial to the development of effective preventive measures against infection. Our findings of 15.4% positive environmental isolates highlight the need for further attention to disinfection of inanimate hospital environment and control of contacts between staff and patients. Moreover use of some antimicrobial agents must be restricted due to existence of high resistance to them.
The revelation that 40.7% of isolates were multi-drug resistant is not only significant but also instructive. Multidrug resistant Pseudomonas aeruginosa is quite problematic in patients with burn injuries and may illustrate the importance of selective pressure of antibiotics. In a study of urinary MDR P. aeruginosa isolates in Jos, Nigeria, all the 100% isolates of P. aeruginosa were resistant to penicillin, cloxacillin, tetracycline, nitrofurantoin and nalidixic acid while 67% were sensitive to augmentin, 92% to ofloxacin, 92% to ciprofloxacin and 86% to cefuroxime (Jombo et al., 2008) . The resistance pattern of P. aeruginosa from urine against antibiotics was extremely high. Such a scenario will heighten the presence and transmission of P. Aeruginosa from conveniences as well.
To overcome inappropriate treatment of burn patients infected with Pseudomonas, aeruginosa periodic antibacterial susceptibility surveys for bacterial isolates in burn units are recommended.
CONCLUSION
Pseudomonas aeruginosa is an opportunistic pathogen with an innate ability to persist during infections due to its high rate of resistance to many drugs including ceftazidime, ciprofloxacin, piperacillin, imipenem, pipereracillin/tazobactam and aztreonam. These antibiotics are top of the range first line therapy candidates for bacteria -associated infections. Evidence of high prevalence of clinical and environmental MRPA reported in this study and their apparent resistant patterns observed provides the rationale for strict enforcement of infection prevention protocol to minimize cross transmission of bacterial pathogens in hospital burn units and consequent disease burden arising from MRPA.
